Form 4: NATR Executive Gains Shares from Performance Vesting

NATURE'S SUNSHINE PRODUCTS, INC. EVP, Global Supply Chain, Martin A. Gonzalez, acquired shares through performance-based restricted stock unit vesting after achieving an Adjusted EBITDA milestone.

Summary

• Martin A. Gonzalez, EVP, Global Supply Chain at Nature's Sunshine Products, Inc. (NATR), reported transactions on November 4, 2025.
• Gonzalez acquired a total of 5,795 common shares (2,885 + 2,910) through the vesting of performance-based restricted stock units (RSUs).
• These vestings were triggered by the achievement of an adjusted EBITDA milestone of $46.2 million over a rolling 12-month period.
• The RSUs originated from grants on July 21, 2022, and April 20, 2023.
• For each grant, half of the target shares vested upon milestone achievement, with the remaining half scheduled to vest one year later.
• A total of 1,673 common shares (833 + 840) were disposed of at a price of $13.75 per share to cover tax obligations related to the RSU vesting.
• Following these transactions, Gonzalez beneficially owns 69,640 common shares directly.

Sentiment

Score: 7

Explanation: The filing indicates successful achievement of performance milestones, leading to executive share vesting, which is a positive signal for operational performance and management alignment. The share disposal for taxes is a routine event.

Positives

• Achievement of a significant adjusted EBITDA milestone of $46.2 million over a rolling 12-month period, indicating strong operational performance.
• Vesting of performance-based restricted stock units for a key executive, aligning management incentives with company performance.
• The structure of the RSU grants, with half vesting now and half in one year, encourages continued executive retention and performance.

Negatives

• Disposal of 1,673 common shares to cover tax liabilities, which is a common practice but reduces the executive's direct ownership slightly in the short term.

Future Outlook

Half of the performance-based restricted stock units from both the July 21, 2022, and April 20, 2023, grants are scheduled to vest one year following the achievement of the Adjusted EBITDA milestone, indicating future share acquisitions for the executive.

Industry Context

The vesting of performance-based restricted stock units tied to Adjusted EBITDA milestones is a common practice in the consumer health and wellness industry to incentivize executive performance and align their interests with shareholder value creation. Achieving a $46.2 million Adjusted EBITDA milestone suggests Nature's Sunshine Products is meeting or exceeding internal operational targets, which can be a positive signal in a competitive market.

Comparison to Industry Standards

• The use of performance-based restricted stock units (RSUs) tied to financial metrics like Adjusted EBITDA is a standard executive compensation practice across various industries, including consumer health and wellness.
• Companies like Herbalife Nutrition Ltd. (HLF) and USANA Health Sciences, Inc. (USNA) also utilize similar long-term incentive plans to motivate executives.
• The specific Adjusted EBITDA target of $46.2 million is an internal company benchmark, and its achievement indicates successful execution against pre-defined operational goals, which is generally viewed favorably compared to companies that fail to meet such targets.

Stakeholder Impact

• Shareholders: Positive signal regarding executive performance and alignment, potentially indicating strong company fundamentals.
• Employees: May signal a healthy company environment and successful achievement of corporate goals.
• Management: Direct financial benefit through RSU vesting, reinforcing incentive structures.

Next Steps

• The remaining half of the performance-based restricted stock units from the July 21, 2022, grant will vest one year after the milestone achievement.
• The remaining half of the performance-based restricted stock units from the April 20, 2023, grant will vest one year after the milestone achievement.

Key Dates

Recommendation

The filing reports a routine insider transaction where an executive's performance-based restricted stock units vested due to the achievement of an Adjusted EBITDA milestone. While the milestone achievement is a positive indicator of operational success, this Form 4 primarily reflects a compensation event rather than a new strategic development or significant change in company fundamentals that would warrant a 'buy' or 'sell' recommendation. The executive's net increase in beneficial ownership, after tax withholdings, is a modest positive, but not a strong catalyst for a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while monitoring future company performance and broader market conditions.

Keywords

NATURE'S SUNSHINE PRODUCTS, NATR, SEC Form 4, Insider Transaction, Restricted Stock Units, RSU Vesting, Adjusted EBITDA, Executive Compensation, Martin A. Gonzalez, Share Ownership